Immunotherapy of prostate cancer in a murine model using a novel GnRH based vaccine candidate

Vaccine

Volumn 25, Issue 50, 2007, Pages 8460-8468

  Junco, Jesús A ^a   Peschke, Peter ^b   Zuna, Ivan ^b   Ehemann, Volker ^c   Fuentes, Franklin ^a   Bover, Eddy ^a   Pimentel, Eulogio ^a   Basulto, Roberto ^a   Reyes, Osvaldo ^a   Calzada, Lesvia ^a   Castro, María D ^a   Arteaga, Niurka ^a   López, Yovisleidis ^a   Garay, Hilda ^a   Hernández, Héctor ^a   Bringas, Ricardo ^a   Guillén, Gerardo E ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cancer vaccines; Hormone sensitive prostate cancer; Immunotherapy

Indexed keywords

4GLUTAMYLHISTIDYLTRYPTOPHYLSERYLTYROSYLPROLYLGLYCYLAMIDE; ANDROGEN; GONADORELIN ANTIBODY; PLACEBO; SYNTHETIC PEPTIDE; TESTOSTERONE; TETANUS TOXOID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CONTROLLED STUDY; DRUG FORMULATION; DRUG MECHANISM; DRUG SAFETY; HELPER CELL; IMMUNOGENICITY; IMMUNOTHERAPY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RAT;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES; CANCER VACCINES; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; GONADOTROPIN-RELEASING HORMONE; HUMANS; IMMUNOTHERAPY; MALE; MANNITOL; OLEIC ACIDS; PEPTIDE FRAGMENTS; PROSTATIC NEOPLASMS; RATS; TESTOSTERONE; TETANUS TOXOID; VACCINES, SYNTHETIC;

EID: 36249030558     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.09.033     Document Type: Article

References (44)

1. Huggins C., and Hodges C.V. Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1 (1941) 293-297
2. Labrie F., Dupont A., Belanger A., St-Arnaud R., Giguere M., Lacouciere Y., et al. Treatment of prostate cancer with gonadotropin-releasing hormone agonists. Endocrinol Rev 7 (1986) 67-74
3. Casper R.F. Clinical uses of gonadotropin-releasing hormone analogues. Can Med Assoc J 144 (1991) 53-158
4. Gual C., Garza-Flores J., Menjivar M., Gutierrez-Najar A., Pal R., and Talwar G.P. Ability of an anti-luteinizing hormone-releasing hormone vaccine to inhibit gonadotropins in postmenopausal women. Fertil Steril 67 (1997) 404-407
5. Etlinger H.M., Felix A.M., Gillessen D., Heimer E.P., Just M., Pink J.L.R., et al. Assessment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malarial parasites Plasmodium falciparum. J Immunol 140 (1988) 626
6. Wang C.Y., Chang T.Y., Walfield A.M., Ye J., Shen M., Shen S.P., et al. Efecctive Synthetic peptide vaccine for foot-and-mouth disease in swine. Vaccine 20 (2002) 2603
7. Stevenson G.T. Immunotherapy of non metastatic complication of malignant disease. Lancet 353 (1999) 340-353
8. Jayashankar R., Chaudhari M., Singh O.M., Alam A., and Talwar G.P. Semisynthetic anti-LHRH vaccine causing atrophy of the Prostate. Prostate 14 (1989) 3-11
9. Rovan E., Fiebiger E., Kalla N.R., Talwar G.P., Aultzky W., and Frick J. Effect of active immunization to LHRH on the fertility and hidtoarchitecture of the reproductive organs of male rat. Urol Res 20 (1992) 323-334
10. Beekman N.J., Schaaper W.M., Turkstra J.A., and Meloen R.H. Highly immunogenic and fully synthetic peptide-carrier constructs targeting GnRH. Vaccine 17 (1999) 2043-2050
11. Miller L.A., Johns B.E., and Killian G.J. Immunocontraception of white-tailed deer with GnRH vaccine. Am J Reprod Immunol 44 (2000) 266-274
12. Meloen R.H., Turkstra J.A., Lankhof H., Puijk W.C., Schaaper W.M., Dijkstra G., et al. Efficient immunocastration of male piglets by immunoneutralization of GnRH using a new GnRH-like peptide. Vaccine 12 (1994) 741-747
13. Talwar G.P., Raina K., Gupta J.C., Ray R., Wadhwa S., and Ali M.M. A recombinant luteinising-hormone-releasing hormone immunogen bioeffective in causing prostatic atrophy. Vaccine 22 (2004) 3713-4372
14. Millar R.P., King J.A., Davidson J.S., and Milton R.C. Gonadotrophin-releasing hormone-diversity of functions and clinical applications. S Afr Med J 72 (1987) 748-755
15. Fink G. Gonadotropin secretion and its control. In: Knobil E., and Neill J.D. (Eds). The physiology of reproduction (1988), Raven Press, New York 1349-1377
16. Talwar G.P. Vaccines for control of fertility and hormone-dependent cancers. Immunology and Cell Biology 75 (1997) 184-189
17. Simms M.S., Schofield D.P., Jacobs E., Michaeli D., et al. Anti GnRH antibodies can induce castrate levels of testosterone in patients with advanced prostate cancer. Br J Cancer 83 (2000) 443-446
18. Ghosh S., and Jackson D.C. Antigenic and immunogenic properties of totally synthetic peptide-based anti-fertility vaccines. Int Immunol 11 (1999) 1103-1110
19. Silversides D.W., Murphy B.D., MisraV, and Mapletoft R.J. Monoclonal antibodies against LHRH: development and immunoactivity in vivo and in vitro. J Reprod Immunol 7 (1995) 171-184
20. Jacobs E., Watson S.A., Michaeli D., Ellis I.O., and Robertson J.F. Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7 human breast cancer xenografts. Br J Cancer 80 (1999) 352-359
21. Schutze M.-P., Leclerc C., Jolivet M., Audibert F., and Chedid L. Carrier-induced epitopic suppression, a major issue for future synthetic vaccines. J immunol 135 (1985) 2319-2322
22. Gaur A., Arunan K., Singh O.M., and Talwar G.P. By pass by an alternate carrier of acquired unresponsiveness to hCG upon repeated immunization with tetanus conjugated vaccine. Int Immunol 2 2 (1990) 151-155
23. Sad S., Gupta H.M., Talwar G.P., and Raghupathy R. Carrier induced suppression of the antibody response to self hapten. Immunlogy 74 (1991) 223-227
24. Finstad C.L., Wang C.Y., Kowalsky J., Zhang M., Li M., Li X., et al. Synthetic luteinizing hormone releasing hormone (LHRH) vaccine for effective androgen deprivation and its application to prostate cancer immunotherapy. Vaccine 22 (2004) 1300-1313
25. Bringas R, Basulto R, Reyes O. De la Fuente J. Vaccine preparation for reversible mammals immunocastration. 2000. PCT patent N0. A61K37/38, C07K 7/00.
26. Basulto R., Milanés C., Rojas A., Fuentes F., Izquierdo N., Bertot J.A., et al. Effects of GnRH immunization in the testicular structure and function of adult dogs. Biotecnología Aplicada 20 (2003) 20-24
27. Hougten R.A., De Graw S.T., Bray M.K., Hoffmann S.R., and Frizzell N.D. Simultaneous multiple peptide Synthesis: The rapid preparation of large numbers of discrete peptides for biological, immunological and methodological studies. Biotecniques 4 (1986) 522-526
28. Peschke P., Klein V., Wolber G., Friedrich E., and Hahn E.W. Morphometric analysis of bromodeoxyuridine distribution and cell density in the rat Dunning prostate tumor R3327-AT-1 following treatment with radiation and/or hyperthermia. Histol Histopathol 14 (1999) 461-469
29. Ehemann V., Hashemi B., Lange A., and Otto H.F. Flow cytometric DNA analysis and chromosomal aberrations in malignant glioblastomas. Cancer Lett 138 (1999) 101-106
30. Herzemberg L.A., and Tokuhisa T. Epitope specific regulation. I. Carrier specific induction of suppression for IgG anti-hapten antibody responses. J Exp Med 155 (1982) 1730-1740
31. Yamshchov G.V., Barnd D.L., Eastham S., Galavotti H., Patterson J.W., Deacon D.H., et al. Evaluation of peptide vaccine immunogenicity in draining lymph nodes and peripheral blood of melanoma patients. Int j Cancer 5 (2001) 703-711
32. Aguado T., Engers H., Pang T., and Pink R. Novel adjuvants currently in clinical testing November 2-4, 1998, Fondation Meriux, Annecy, France: A meeting sponsored by the World Health Organization. Vaccine 17 (1999) 2321-2328
33. Benmohamed L., Thomas A., Bossus M., Brahhimi K., Wubben J., Grass-Masse H., et al. High immunogenicity in chimpanzees of peptides and lipopeptides derived from four new plasmodium falciparum pre-erythrocytic molecules. Vaccine 18 (2000) 2843-2855
34. Ronald B.M., Diveley J., Jensen Fred, and Carlo J.D. In vitro immune function after vaccination with an inactivated, gp 120-depleted HIV-1 antigen with immunostimulatory oligodeoxynucleotides. Vaccine 18 (2000) 1081-1087
35. Hoskinson R.M., Rigby R.D.G., Mattner P.E., et al. Vaxstrate: An anti-reproductive vaccine for cattle. Australian Journal of Biotechnology 4 (1990) 166-170
36. Smolev J.K., Heston W.D., Scott W.W., and Coffey D. Characterization of the Dunning R3327H prostatic adenocarcinoma: an appropriate animal model for prostatic cancer. Cancer Treat Rep 61 (1977) 273-287
37. Fuerst J., Fiebiger E., Jungwirth A., Mack D., Talwar G.P., Frick J., et al. Effect of active immunization against luteinizing hormone releasing hormone on the androgen sensitive Dunning R3327-PAP and androgen-independent Dunning R3327-AT2.1 prostate cancer sublines. Prostate 32 (1997) 77-84
38. Isaacs J.T., Isaacs W.B., Feitz W.F., and Scheres J. Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancer. Prostate 9 (1986) 261-281
39. Talwar G.P., Singh V., Om S., Das C., Gupta S.K., and Singh G. pituitary and extra-pituitary sites of action of gonadotrophin-releasing hormone: Potential uses of active and passive immunization against gonadotrophin-releasing hormone. Hormones Recept Growth Reproduct 9 (1984) 351
40. Ladd A., Tsong Y.Y., Prabhu G., and Thau R. Effects of long term immunization against LHRH and androgen treatment on gonadal function. J Reperod Immunol 15 (1989) 85
41. Etlinger H.M., Gillessen D., Lahm H.W., Matile H., Schonfeld H.J., and Trzeciak A. Use of prior vaccinations for the development of new vaccines. Science 249 (1990) 423
42. Subash S., Chaujan V.S., Arunan K., and Raghupathy R. Synthetic Gonadotrophin-releasing hormone (GnRH) vaccines incorporating GnRH and synthetic T helper epitopes. Vaccine 11 (1993) 1145-1150
43. Reddy P.R., Rao I.M., Raju V.S., Rukmini V., and Reddy R.L. Direct inhibitory actions of GnRH on accessory reproductive organs of rat. J Steroid Biochem 23 (1985) 819-822
44. Talwar G.P., Diwan M., Dawar H., Frick J., Sharma S.K., and Wadhwa S.N. Counter GnRH vaccine. In: Rajalakshmi M., and Griffin P.D. (Eds). Male contraception: Present and future (1999), New Age Publishers, New Delhi 309-318